Dr. Lalchandani Labs Ltd.BSE: DLCL

Dr. Lalchandani Labs Ltd. Press Release Oct 28 2024

· Issued by Dr. Lalchandani Labs Ltd. via BSE India

Filed with BSE ·

On 6ix: 6ix.com/news/dr-lalchandani-labs-ltd-press-release-oct-28-2024

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani

View Attachment

6ix hasn’t read this filing yet.

Dr. Lalchandani Labs Ltd. on 6ix

Later from Dr. Lalchandani Labs

All Dr. Lalchandani Labs news releases